Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma.
Esposito D, Napolitano F, Maresca DC, Scala M, Amato A, Belli S, Ascione CM, Vallefuoco A, Attanasio G, Somma F, Ianaro A, Russo D, Varricchio S, Mascolo M, Costa C, Villani A, Scalvenzi M, Orlandino G, Troiani T, Servetto A, Bianco R, Ercolano G, Formisano L.
Esposito D, et al. Among authors: ianaro a.
J Immunother Cancer. 2025 Jan 11;13(1):e010421. doi: 10.1136/jitc-2024-010421.
J Immunother Cancer. 2025.
PMID: 39800379
Free article.